A carregar...
Review: Hepatitis C Protease and Polymerase Inhibitors in Development
Hepatitis C infection (HCV) remains a global problem and the current anti-HCV therapies available in the clinic have sustained virologic response rates (SVR) of only about 50%, especially in HCV genotype 1–infected subjects. The SVR is even lower in HIV-HCV co-infected patients, estimated at only ab...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Mary Ann Liebert, Inc.
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2928549/ https://ncbi.nlm.nih.gov/pubmed/18479202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/apc.2007.0199 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|